Zigang Dong

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Venues

Signal transduction and targeted therapy

Oncogene

Oncogenesis

Cell death & disease

Zhengzhou University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhengzhou University Nov 11 2019

China

Professor :: Pathophysiology

Publications

Yunshu Shi, Junyong Wang, Qiang Yuan, Yingying Chen, Miao Zhao, Xiaoyu Li, Zitong Wang, Hao Zhou, Fangli Zhu, Bing Wei, Yanan Jiang, Jimin Zhao, Yan Qiao, Zigang Dong, Kangdong Liu
DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability. Oncogene (2024)
Xuechao Jia, Xinyu He, Chuntian Huang, Jian Li, Zigang Dong, Kangdong Liu
Protein translation: biological processes and therapeutic strategies for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Xuechao Jia, Xinyu He, Chuntian Huang, Jian Li, Zigang Dong, Kangdong Liu
Protein translation: biological processes and therapeutic strategies for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Xuechao Jia, Xinyu He, Chuntian Huang, Jian Li, Zigang Dong, Kangdong Liu
Protein translation: biological processes and therapeutic strategies for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Liting Zhou, Jie Tian, Keke Wang, Yijie Ma, Xiaojie Chen, Hui Luo, Bingbing Lu, Nan Wang, Penglei Wang, Xuejiao Liu, Ran Zhao, Simin Zhao, Jiutao Wang, Wenna Nie, Hong Ge, Wenting Liu, Tingxuan Gu, Kangdong Liu, Mee-Hyun Lee, Xiang Li, Zigang Dong
Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma. Cancer research (2024)
Xuechao Jia, Xinyu He, Chuntian Huang, Jian Li, Zigang Dong, Kangdong Liu
Protein translation: biological processes and therapeutic strategies for human diseases. Signal transduction and targeted therapy 9 (1) (2024)
Xinning Liu, Yanan Jiang, Hao Zhou, Xiaokun Zhao, Mingzhu Li, Zhuo Bao, Zitong Wang, Chenyang Zhang, Zhenliang Xie, Jimin Zhao, Zigang Dong, Kangdong Liu, Zhiping Guo
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1. Cell death & disease 14 (2) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Shuying Yin, Simin Zhao, Jian Li, Kangdong Liu, Xinli Ma, Zihan Zhang, Rui Wang, Jie Tian, Fangfang Liu, Yanming Song, Mengqiu Song, Ran Zhao, Ran Yang, Mee-Hyun Lee, Zigang Dong
NUMA1 modulates apoptosis of esophageal squamous cell carcinoma cells through regulating ASK1-JNK signaling pathway. Cellular and molecular life sciences : CMLS 80 (8) (2023)
Simin Zhao, Jian Li, Qingxin Xia, Kangdong Liu, Zigang Dong
New perspectives for targeting therapy in ALK-positive human cancers. Oncogene (2023)
Xinning Liu, Yanan Jiang, Hao Zhou, Xiaokun Zhao, Mingzhu Li, Zhuo Bao, Zitong Wang, Chenyang Zhang, Zhenliang Xie, Jimin Zhao, Zigang Dong, Kangdong Liu, Zhiping Guo
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1. Cell death & disease 14 (2) (2023)
Xuejiao Liu, Simin Zhao, Keke Wang, Liting Zhou, Ming Jiang, Yunfeng Gao, Ran Yang, Shiwen Yan, Wen Zhang, Bingbing Lu, Feifei Liu, Ran Zhao, Wenting Liu, Zihan Zhang, Kangdong Liu, Xiang Li, Zigang Dong
Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer. Nature communications 14 (1) (2023)
Penglei Wang, Xuechao Jia, Bingbing Lu, Han Huang, Jialin Liu, Xuejiao Liu, Qiong Wu, Yamei Hu, Pan Li, Huifang Wei, Tingting Liu, Dengyun Zhao, Lingwei Zhang, Xueli Tian, Yanan Jiang, Yan Qiao, Wenna Nie, Xinli Ma, Ruihua Bai, Cong Peng, Zigang Dong, Kangdong Liu
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2. Signal transduction and targeted therapy 8 (1) (2023)
Souren Paul, Preston M McCourt, Le Thi My Le, Joohyun Ryu, Wioletta Czaja, Ann M Bode, Rafael Contreras-Galindo, Zigang Dong
Fyn-mediated phosphorylation of Menin disrupts telomere maintenance in stem cells. bioRxiv : the preprint server for biology (2023)
Mengqiu Song, Luping Pang, Mengmeng Zhang, Yingzi Qu, Kyle Vaughn Laster, Zigang Dong
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases. Signal transduction and targeted therapy 8 (1) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Xinning Liu, Yanan Jiang, Hao Zhou, Xiaokun Zhao, Mingzhu Li, Zhuo Bao, Zitong Wang, Chenyang Zhang, Zhenliang Xie, Jimin Zhao, Zigang Dong, Kangdong Liu, Zhiping Guo
Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1. Cell death & disease 14 (2) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Mingzhu Li, Lina Duan, Wenjie Wu, Wenjing Li, Lili Zhao, Ang Li, Xuebo Lu, Xinyu He, Zigang Dong, Kangdong Liu, Yanan Jiang
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC. Oncogenesis 12 (1) (2023)
Penglei Wang, Xuechao Jia, Bingbing Lu, Han Huang, Jialin Liu, Xuejiao Liu, Qiong Wu, Yamei Hu, Pan Li, Huifang Wei, Tingting Liu, Dengyun Zhao, Lingwei Zhang, Xueli Tian, Yanan Jiang, Yan Qiao, Wenna Nie, Xinli Ma, Ruihua Bai, Cong Peng, Zigang Dong, Kangdong Liu
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2. Signal transduction and targeted therapy 8 (1) (2023)
Xinyu He, Yubing Zhou, Wenjing Chen, Xiaokun Zhao, Lina Duan, Hao Zhou, Mingzhu Li, Yin Yu, Jimin Zhao, Yaping Guo, Huihui Gu, Yanan Jiang, Zigang Dong, Kangdong Liu
Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma. Oncogene (2023)
Penglei Wang, Xuechao Jia, Bingbing Lu, Han Huang, Jialin Liu, Xuejiao Liu, Qiong Wu, Yamei Hu, Pan Li, Huifang Wei, Tingting Liu, Dengyun Zhao, Lingwei Zhang, Xueli Tian, Yanan Jiang, Yan Qiao, Wenna Nie, Xinli Ma, Ruihua Bai, Cong Peng, Zigang Dong, Kangdong Liu
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2. Signal transduction and targeted therapy 8 (1) (2023)
Penglei Wang, Xuechao Jia, Bingbing Lu, Han Huang, Jialin Liu, Xuejiao Liu, Qiong Wu, Yamei Hu, Pan Li, Huifang Wei, Tingting Liu, Dengyun Zhao, Lingwei Zhang, Xueli Tian, Yanan Jiang, Yan Qiao, Wenna Nie, Xinli Ma, Ruihua Bai, Cong Peng, Zigang Dong, Kangdong Liu
Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2. Signal transduction and targeted therapy 8 (1) (2023)
Yunfeng Gao, Ming Jiang, Fangqin Guo, Xuejiao Liu, Qi Zhang, Sen Yang, Yiu To Yeung, Ran Yang, Keke Wang, Qiong Wu, Dandan Zhang, Chengjuan Zhang, Kyle Vaughn Laster, Mengmeng Ge, Wenna Nie, Kangdong Liu, Zigang Dong
A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC. Oncogene 41 (42) (2022)
Ning Lu, Tingxuan Gu, Xueli Tian, Simin Zhao, Guoguo Jin, Fredimoses Mangaladoss, Yan Qiao, Kangdong Liu, Ran Zhao, Zigang Dong
Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19. Signal transduction and targeted therapy 7 (1) (2022)
Faisal Aziz, Abhijit Chakraborty, Kangdong Liu, Tianshun Zhang, Xiang Li, Ruijuan Du, Josh Monts, Gang Xu, Yonghan Li, Ruihua Bai, Zigang Dong
Gastric tumorigenesis induced by combining Helicobacter pylori infection and chronic alcohol through IL-10 inhibition. Carcinogenesis 43 (2) (2022)
Zhuo Bao, Ang Li, Xuebo Lu, Zitong Wang, Yin Yu, Wenjie Wu, Lili Zhao, Bo Li, Xiangyu Wu, Kyle Vaughn Laster, Chengjuan Zhang, Yanan Jiang, Zigang Dong, Kangdong Liu
Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A. Cell death & disease 13 (2) (2022)
Fayang Ma, Kyle Laster, Zigang Dong
The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations. Nature communications 13 (1) (2022)
Jiutao Wang, Ning Yao, Yamei Hu, Mingjuan Lei, Meixian Wang, Lu Yang, Satyananda Patel, Xiang Li, Kangdong Liu, Zigang Dong
PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras. Cellular and molecular life sciences : CMLS 79 (10) (2022)
Jian Li, Xinli Ma, Surajit Banerjee, Hanyong Chen, Weiya Ma, Ann M Bode, Zigang Dong
Crystal structure of the human PRPK-TPRKB complex. Communications biology 4 (1) (2021)
Ruijuan Du, Chuntian Huang, Kangdong Liu, Xiang Li, Zigang Dong
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. Molecular cancer 20 (1) (2021)
Qiong Wu, Fangfang Liu, Mengmeng Ge, Kyle Vaughn Laster, Lixiao Wei, Ruijuan Du, Ming Jiang, Jing Zhang, Yafei Zhi, Guoguo Jin, Simin Zhao, Dong Joon Kim, Zigang Dong, Kangdong Liu
BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression. Oncogene (2021)
Yamei Hu, Fangfang Liu, Xuechao Jia, Penglei Wang, Tingxuan Gu, Hui Liu, Tingting Liu, Huifang Wei, Hanyong Chen, Jiuzhou Zhao, Ran Yang, Yingying Chen, Zigang Dong, Kangdong Liu
Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3. Oncogene 40 (23) (2021)
Hai Huang, Mee-Hyun Lee, Kangdong Liu, Zigang Dong, Zeayoung Ryoo, Myoung Ok Kim
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential. Cancers 13 (9) (2021)
Hui Liu, Zigang Dong
Cancer Etiology and Prevention Principle: "1 + X". Cancer research 81 (21) (2021)
Guoguo Jin, Mingyang Yan, Kangdong Liu, Ke Yao, Hanyong Chen, Chengjuan Zhang, Yang Yi, Kanamata Reddy, Dhilli Rao Gorja, Kyle Vaughn Laster, Zhiping Guo, Zigang Dong
Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer. Oncogene 39 (43) (2020)
Ruijuan Du, Chuntian Huang, Hanyong Chen, Kangdong Liu, Pu Xiang, Ning Yao, Lu Yang, Liting Zhou, Qiong Wu, Yaqiu Zheng, Mingxia Xin, Zigang Dong, Xiang Li
SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway. Oncogene 39 (31) (2020)
Zhenjiang Zhao, Guoguo Jin, Ke Yao, Kangdong Liu, Fangfang Liu, Hanyong Chen, Keke Wang, Dhilli Rao Gorja, Kanamata Reddy, Ann M Bode, Zhiping Guo, Zigang Dong
Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma. Molecular carcinogenesis 58 (6) (2019)
Xiaomeng Xie, Xueyin Zu, Feifei Liu, Ting Wang, Xiangyu Wang, Hanyong Chen, Kangdong Liu, Penglei Wang, Fangfang Liu, Yan Zheng, Ann M Bode, Zigang Dong, Dong Joon Kim
Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo. Molecular carcinogenesis 58 (7) (2019)
Yonghun Sung, Jain Jeong, Ri Jin Kang, Minjee Choi, Song Park, Wookbong Kwon, Jinhee Lee, Soyoung Jang, Si Jun Park, Sung-Hyun Kim, Junkoo Yi, Seong-Kyoon Choi, Mee-Hyun Lee, Kangdong Liu, Zigang Dong, Zae Young Ryoo, Myoung Ok Kim
Lin28a expression protects against streptozotocin-induced β-cell destruction and prevents diabetes in mice. Cell biochemistry and function 37 (3) (2019)
Feifei Liu, Xueyin Zu, Xiaomeng Xie, Kangdong Liu, Hanyong Chen, Ting Wang, Fangfang Liu, Ann M Bode, Yan Zheng, Zigang Dong, Dong Joon Kim
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth. Molecular carcinogenesis 58 (4) (2018)

Zigang Dong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zigang Dong